Mon panier

Recombinant Monoclonal Anti-PTK7 Antibody, Rabbit (P2A01)

Avis des utilisateurs
Numéro de produit/spécification
Prix
Qté
HGS-M2715-20ul
$160.00
HGS-M2715-100ul
$470.00
ETA of in-stock products:2 business days
Total des articles Montant du produit$ 0

Détails du produit

  • Background

    Recombinant Monoclonal Anti-PTK7 Antibody, Rabbit (P2A01) is a PTK7 primary antibody for IHC application.
    PTK7 is a member of the receptor tyrosine kinase (RTK) superfamily, plays a critical role in regulating cell polarity, migration and tissue homerostasis during vertebrate development. PTK7 can form heterdimers and function as a signal enhancer or co-receptor, deeply involved in the switching of WNT signaling pathway. PTK7 is overexpressed in a variety of tumors, such as cervical cancer, colorectal cancer, breast cancer and so on, where it is closely associated with tumorigenesis and progression.

  • Product Specifications

    Host Species
    Rabbit
    Isotype
    Rabbit IgG, Rabbit Kappa
    Clone
    P2A01
    Application
    IHC-P
    Form
    Liquid
    Clonality
    Monoclonal
    Reactivity
    Human
    Synonyms
    CCK4
    Concentration
    0.9~1.1 mg/ml
    Specificity
    React with PTK7 protein on the membrane of target cell/tissue
  • Experiment Protocol

    LEICA Experiment Protocol

  • Storage

    Shipped at 4°C, Blue Ice. Store at +4°C for short term (1-2 weeks). Store at -20°C for long term.
    Avoid freeze / thaw cycle. Upon delivery aliquot. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Les clients ont également consulté

Avis des utilisateurs
Publier un commentaire

Progrès de frontière

 
Progrès du développement médicamenteux
  • Nom anglais:

    Protein-tyrosine kinase 7

  • Catégorie:

  • Nombre de médicaments répertoriés:

    0 Détails

  • Nombre de médicaments cliniques:

    8 Détails

  • Étape de développement la plus élevée:

    Phase 2 Clinical

Drug Candidate Licensing
More
  • Informations de base sur le produit
  • Détails du produit
  • Les clients ont également consulté
  • Avis des utilisateurs